Papers
Topics
Authors
Recent
Search
2000 character limit reached

Contrastive CUR: Interpretable Joint Feature and Sample Selection for Case-Control Studies

Published 15 Aug 2025 in stat.ME and stat.AP | (2508.11557v1)

Abstract: Dimension reduction is an essential tool for analyzing high dimensional data. Most existing methods, including principal component analysis (PCA), as well as their extensions, provide principal components that are often linear combinations of features, which are often challenging to interpret. CUR decomposition, another matrix decomposition technique, is a more interpretable and efficient alternative, offers simultaneous feature and sample selection. Despite this, many biomedical studies involve two groups: a foreground (treatment or case) group and a background (control) group, where the objective is to identify features unique to or enriched in the foreground. This need for contrastive dimension reduction is not well addressed by existing CUR methods, nor by contrastive approaches rooted in PCAs. Furthermore, they fail to address a key challenge in biomedical studies: the need for selecting samples unique to the foreground. In this paper, we address this gap by proposing a Contrastive CUR (CCUR), a novel method specifically designed for case-control studies. Through extensive experiments, we demonstrate that CCUR outperforms existing techniques in isolating biologically relevant features as well as identifying sample-specific responses unique to the foreground, offering deeper insights into case-control biomedical data.

Authors (3)

Summary

No one has generated a summary of this paper yet.

Paper to Video (Beta)

No one has generated a video about this paper yet.

Whiteboard

No one has generated a whiteboard explanation for this paper yet.

Open Problems

We haven't generated a list of open problems mentioned in this paper yet.

Continue Learning

We haven't generated follow-up questions for this paper yet.

Collections

Sign up for free to add this paper to one or more collections.

Tweets

Sign up for free to view the 1 tweet with 2 likes about this paper.